More than 1,000 delegates from around the world gathered at the International Convention and Exhibition Centre Sydney (ICC Sydney) for four days of cutting-edge science at the 21st International Symposium on Paediatric Neuro-Oncology (ISPNO 2026).
The symposium is the premier international meeting that brings together the world’s best researchers, clinicians and diverse healthcare professionals involved in this specialised field. Australia’s innovation in this area and the appeal of the host destination contributed to strong registrations, which reached 20% above the anticipated attendance, with 70% of delegates from overseas.
Through sessions, workshops and professional collaborations during the event, the biennial meeting’s key objective is to achieve better outcomes for children and adolescents with central nervous system tumours – the single disease that causes the most childhood deaths.
Fast facts
- Event: 21st International Symposium on Paediatric Neuro-Oncology (ISPNO 2026)
- When: 28 June – 1 July 2026
- Where: Sydney/Warrane
- Venue: ICC Sydney
- Professional conference organiser: ASN Events
- Attendees: 1,000 delegates from 56 countries

Team Australia approach
The ISPNO series is organised by the International Society of Paediatric Neuro-Oncology (ISPN) in collaboration with its local hosts. Founded in 1972, ISPN aims to improve the health and welfare of children needing neurosurgical care through scientific research and close international cooperation.
The symposium’s Australian hosts were the Children’s Cancer Institute Australia and the Sydney Children’s Hospital Kids Cancer Centre. Both have established a national and international reputation for scientific excellence and leadership in global research.
Strong support to attract and help stage the symposium was provided by Tourism Australia’s Business Events Bid Fund Program, along with Business Events Sydney and the symposium venue, ICC Sydney, showcasing the collaborative destination approach.
“I’m incredibly proud. Australia has some of the leading research in the world and has a fantastic medical research community – there’s a lot of innovation happening here and we are known for the research we do.”
Professor David Ziegler, director of the Brain Tumour Program at Sydney Children’s Hospital and head of brain tumour research at Children’s Cancer Institute
First time to Australia for ISPNO
This was the first time the symposium came to Australia and also its first visit to the Southern Hemisphere. Organisers indicated that it was time for the symposium to come to Australia and shine on the global stage, as the country is home to some of the world’s most innovative treatments and is a leader in the paediatric neuro-oncology field. The symposium gave Australian researchers an invaluable opportunity to showcase their expertise and findings to their global colleagues.
Australia’s proximity and accessibility to Asia encouraged attendance by delegates from the Asia Pacific region, many of whom, as early-career professionals, had been less likely to attend gatherings further afield – broadening the global reach and value of the symposium discussions.
“Different areas of the world do things a little bit differently. We look for an area of expertise that is different, is new and could bring something to the field. The Australian group in neuro-oncology was a very strong one and have made many wonderful contributions. It was an acknowledgement of how important they were to the field and how much we could learn from them.”
Dr Roger Packer, director and chief of the Brain Tumor Institute at Children’s National Hospital in Washington DC
The strong appeal of Sydney and Australia
Sydney’s status as an international city, its warm and welcoming nature and its reputation as a place of proven collaboration were also factors in its selection. With the convention centre located right in the heart of the city, delegates could walk and explore the city safely on foot.
Australia being an English-speaking country was also seen as a positive, along with its affordability for international delegates, good weather, great facilities and strong support from all levels of government.
Access to Australia’s International Event Coordinator Network (IECN) – a free advisory service run by the federal government’s Department of Home Affairs to help event organisers with visa information for international delegates – also contributed to the ease of organising ISPNO 2026.
“The one thing that really sets Australia apart is its people. Warm, welcoming, incredible hospitality, a can-do attitude and the value proposition is also there from a financial perspective. Being able to work with a destination that has an international event coordinator network was pivotal to make sure of a really strong international attendance.”
Hannah Pickford, executive director of ASN Events, professional conference organiser for ISPNO 2026

A taste of Australia
One of the social programme highlights was a cruise for delegates from Darling Harbour across to Sydney’s iconic Luna Park – a historic, heritage-listed amusement park on the waterfront of Sydney Harbour – where they attended the spectacular gala event.
A visit to Wildlife Sydney Zoo, an indoor wildlife park at Darling Harbour next to ICC Sydney, showcased unique Australian wildlife such as koalas, kangaroos, wombats, platypuses, Tasmanian devils and a saltwater crocodile named Rocky, giving delegates a genuine taste of Australia.
Many international delegates made the most of their visit to Sydney with pre- and post-symposium tours, including whale watching on Sydney Harbour, catching the iconic Sydney ferry across the harbour to Manly, and venturing further afield to experience the natural attractions of the Blue Mountains, approximately 100km west of the city.
“We’ve [the local organising committee] also really tried to make sure that not just the science is great but that the delegate experience is great – they get time to see the city and we really showcase the best of what Sydney and Australia has to offer.”
Professor David Ziegler, director of the Brain Tumour Program at Sydney Children’s Hospital and head of brain tumour research at Children’s Cancer Institute

Creating lasting legacies
Conferences leave an impact on the host destination and the field of research long after the event. ISPNO 2026 was no exception, delivering longer-term opportunities for new collaborations, shared clinical trials and investment thanks to relationships formed in the host city.
The Education Day and Young Investigator initiatives connected emerging professionals with global leaders, while 30 travel grants broadened access to the international scientific community.
Providing a direct platform for research investment, the Cure Fund offered up to US$50,000 for innovative early-stage research, with four of the five semi-finalists representing Children’s Cancer Institute Australia or UNSW Sydney.
Following the conference, international researchers visited Children’s Cancer Institute Australia and Sydney Children’s Hospital, connecting with ZERO Childhood Cancer researchers and identifying opportunities for future collaboration.











